Logo | Name | Σ | Employees | ||
---|---|---|---|---|---|
Proteintech Group For when you need it all. We're here. For when you need it all. We're here. We know scientists give it their all every day to reach their goals. Wherever your research takes you, Proteintech provides all of the antibodies you need to help you do that. All types and forms of antibodies are in stock for your experiment. We’ll be there for every step of your journey. With our GMP capabilities and recombinant custom antibody platform, we can provide the support to scale up from bench to clinic. Search the full catalog at ptglab.com. Whole Protein Antigen Antibodies, Polyclonal … Type: SMB Activities: biotech deeptech legaltech Technologies: Synthetic Biology | 7 | 2 | 4 | 188 | |
STARRY STARRY's diverse staff nurtures children, strengthens families, & restores hope through free child and family services. STARRY's diverse staff nurtures children, strengthens families, and restores hope through no-cost family counseling, fatherhood, and family preservation services. STARRY offers free community counseling across 30+ Texas counties, guided by professionalism, grace, and love. We provide an array of dynamic free fatherhood services in Bell, Coryell, McLennan, and Williamson Counties. STARRY's Family Preservation provides therapeutic support to foster children, foster families, and biological families through family engagement services and case management services. Counseling, Fatherhood, Family Resource Center, and Family Wellbeing Type: SMB Activities: kidtech healthtech Technologies: Synthetic Biology | 14 | 3 | 8 | 104 | |
Global Health Strategies With offices in the US, the UK, India, China, Brazil, Kenya and South Africa Global Health Strategies (GHS) is an international consulting company that specializes in global health communications, advocacy, research and strategy. We focus on public health issues that impact developing nations and emerging markets. Our clients include leading foundations, industry, NGOs, government agencies, academic institutions and product development. Our work is driven by a passion for improving the health and wellbeing of individuals and communities around the world. We offer the skills, knowledge and goal-driven efficiency to enhance our clients' efforts to address some of the world’s toughest … Type: SMB Activities: govtech Technologies: Synthetic Biology | 14 | 1 | 11 | 209 | |
Alligator Bioscience AB Alligator Bioscience AB is a clinical-stage biotechnology company developing tumor-directed immuno-oncology antibody drugs. Alligator’s portfolio includes several promising drug candidates, with the CD40 agonist mitazalimab as its key asset. Furthermore, Alligator is co-developing ALG.APV-527 with Aptevo Therapeutics Inc., several undisclosed molecules based on its proprietary technology platform, Neo-X-PrimeTM, and novel drug candidates based on the RUBYTM bispecific platform with Orion Corporation. Out-licensed programs include AC101/HLX22, in Phase 2 development, by Shanghai Henlius Biotech Inc. and an undisclosed target to Biotheus Inc. Alligator ́s technology platform comprises the proprietary technologies ALLIGATOR-GOLD® and FIND®. ALLIGATOR-GOLD® is a human antibody library containing more … Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 0 | 0 | 0 | 62 | |
Mercodia Expertise that matters Mercodia utilizes its 30+ years of experience as a world-leading manufacturer of cardiometabolic immunoassays to provide tailored bioanalysis solutions for pharma and biotech companies. We specialize in assay development and validation, PK/PD, immunogenicity testing, and biomarker testing, mainly focusing on large molecules, peptides, and oligonucleotide therapeutics in preclinical and clinical development. We are GLP-certified and work in accordance with ICH GCP, EMA, and FDA guidelines. Our team of expert scientists quickly provides reproducible, reliable, and high-quality data that meets regulatory requirements. We prioritize speed and flexibility while delivering cost-effective solutions. Our vision is to improve human health … Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 2 | 0 | 2 | 79 | |
Calliditas Therapeutics Pioneering treatments for rare diseases. We harness scientific & commercial expertise to improve the lives of patients. Calliditas is a specialty pharmaceutical company developing high value products for patients with significant unmet medical needs. With a highly experienced, dynamic management team, Calliditas draws on its extensive experience of pharmaceutical development and marketing to efficiently identify and progress valuable and de-risked products. Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 5 | 2 | 0 | 238 | |
Emergex Vaccines A UK biotechnology company developing T cell-priming immune set-point candidates against infectious diseases. Emergex, a clinical-stage, privately-held biotechnology company headquartered in Abingdon, UK, with an operating subsidiary in Doylestown, Pennsylvania, USA, is pioneering the development of 100% synthetic T cell-priming immune set-point vaccine candidates that harness and direct the body’s natural CD8+ T cell immune response to destroy and clear pathogen-infected cells in order to provide protection against some of the world’s most urgent health threats. First indications pursued are against infectious diseases caused by: [i] viruses, amongst which are Betacoronavirus, Dengue Fever and Universal Influenza A, including pandemic influenza, … Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 1 | 0 | 1 | 43 | |
COFARES [Automatic translation follows] Health moves us Cofares is a company established exclusively with pharmaceutical capital that operates under the cooperative corporate formula. With a turnover in 2012 of more than 2.5 billion euros, it is the leading company in the distribution of medicines in Spain. Distribution of medicines Type: Large company Activities: deeptech Technologies: Synthetic Biology | 20 | 2 | 7 | 1,541 | |
Sophion Bioscience Pioneering Ion Channels Sophion was founded in the year 2000 by a group of passionate electrophysiologists, all having the shared purpose of making patch clamping objective and independent of user skills to provide faster, more accurate and objective patch clamping results. “To take the voodoo out of patch clamping”. Over the past twenty years, we have developed from a startup into a global organization, but the passion and drive to provide high-performance patch clamp solutions persist. With our complete technical, biological and application support we help our partners to achieve their targets, and through the continued development of our QPatch … Type: SMB Activities: deeptech Technologies: Data Analytics Synthetic Biology | 1 | 0 | 1 | 110 | |
Bavarian Nordic For us, it is all about improving and saving lives Improving and saving lives through innovative vaccines is at the heart of what we do in Bavarian Nordic, and we have more than 25 years of experience in developing life-saving vaccines. We are a fully integrated vaccine company focused on the development, manufacturing and commercialization of our vaccines- We are a global leader in smallpox and mpox vaccines, which have been developed through our long-standing partnership with the U.S. Government to enhance the public health preparedness and have a strong portfolio of vaccines for travelers and endemic diseases. Our values … Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 3 | 1 | 4 | 1,439 | |
BRAIN Biotech AG Developing a biobased future is our passion. Industrial biotechnology is our business. BRAIN Biotech AG is a leading European supplier of enzyme products, production strains and bioprocess solutions for more sustainable and efficient industrial processes. We focus on the fields of nutrition, health and environment. BRAIN Biotech AG is the parent company of the international BRAIN Biotech Group. The Group's business activities are divided into the segments BioProducts, BioScience and BioIncubator. The BioProducts segment comprises the product business with specialty enzymes and other proteins, for which the Group operates fermentation facilities in the United Kingdom and production facilities in continental … Type: SMB Activities: healthtech biotech civictech deeptech Technologies: Batteries Bio sourced materials Synthetic Biology | 5 | 1 | 4 | 189 | |
RAUMEDIC We develop solutions for life together with people who care. RAUMEDIC has a clear goal: to break new ground to improve the diagnosis and treatment of diseases. In doing so, Raumedic focuses on polymer-based solutions for medical and pharmaceutical applications, as well as on products for intensive care. With more than 70 years of experience in the areas of extrusion, injection molding and assembly, the company with a global workforce of about 1,000 people turns customer ideas into mature products. We develop and produce customized components for our partners, including tubing, catheters and molded parts as well as complex groups … Type: SMB Activities: deeptech healthtech Technologies: Synthetic Biology | 2 | 1 | 1 | 364 | |
Nicox Maintain vision and improve ocular health Nicox is an international ophthalmic R&D company, aiming to build a diversified portfolio of therapeutic products addressing the needs of eyecare practitioners and patients around the world. Our global growth strategy is focused on outstanding international collaborations and on our proprietary programs including those from our nitric oxide-donating research platform. For more information please visit www.nicox.com Pharmaceuticals, Ophthalmology, and Research and Development Type: SMB Activities: healthtech manufacturing Technologies: Synthetic Biology | 2 | 2 | 0 | 52 | |
STELLA SURGICAL [Automatic translation follows] The new way of transplantation Stella Surgical is a European company based in the South of France. It was created to meet the needs of transplant surgeons, organ harvesting and transplant teams, and organ transporters. Our promise: to increase the number of available grafts and their safety throughout the entire transplant process. Thus, we design, develop and market connected and innovative medical devices so that coordination teams (harvesting and transplant) can plan transplants in the best possible conditions. Patients will therefore be able to benefit from better conditions during their transplant. Type: SMB Activities: deeptech healthtech manufacturing Technologies: Synthetic Biology | 7 | 2 | 6 | 6 | |
Biospace Lab Imaging for discoveries Molecular Imaging in Real Time Biospace Lab - originally Biospace Mesures - was founded in 1989 by Nobel Prize winner Georges Charpak to provide fellow researchers in biology with innovative imaging tools based on his discoveries in high-energy physics and particle detection. Since then, Biospace Lab has pursued and created strong links with medical, pharmaceutical and scientific communities to bring relevant and creative solutions to biomedical imaging needs. Today, Biospace Lab range of instruments, developed with patented technologies, is dedicated to high-performance imaging for pre-clinical research in drug discovery and biology. Biospace Lab instruments and software are … Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology | 3 | 0 | 3 | 15 | |
Oncodesign Services A leading CRO in drug discovery and preclinical services Oncodesign Services is a Contract research organization (CRO) specializing in drug discovery and preclinical services. Founded in 1995, Oncodesign Services mission’ is to contribute to the discovery of innovative therapies with unmet medical needs, in particular in oncology, inflammation and infectious diseases. From target identification, hit-to-lead and lead optimization to IND filing, Oncodesign Services support the R&D programs of customers globally (whether pharmaceutical companies, biotechs, public research institutions, etc.). Oncodesign Services offers a full spectrum of services in medicinal chemistry, DMPK, pharmaco-imaging, bioanalysis, in vivo/In vitro pharmacology (including humanized models). This … Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 14 | 9 | 8 | 18 | |
Teva Santé [Automatic translation follows] Who is Teva Santé? Present in more than 60 countries, the leading producer of active ingredients for the pharmaceutical industry, Teva is one of the largest pharmaceutical laboratories in the world. Its range of drugs, generic or not, allows the treatment of more than 120 pathologies. In France, its drugs concern one prescription out of 12. But Teva's involvement goes well beyond simple drugs. Its action is part of commitments to patients, doctors, pharmacists and caregivers. With regard to the latter, the laboratory is particularly committed to helping them identify, understand and master their role, and improve … Type: SMB Activities: healthtech manufacturing Technologies: Synthetic Biology | 13 | 1 | 10 | 265 | |
EHN Canada EHN Canada is the nation's largest network of industry-leading mental health and addiction treatment centres. With over 100 years of collective experience in providing high quality inpatient and outpatient services, EHN Canada provides a comprehensive, compassionate, and truly national therapeutic option to patients, families, healthcare practitioners, and corporate partners. Under the umbrella of EHN Canada, we are able to harness the power of Canada's leading treatment centres for addiction, trauma, and mental health: Edgewood Treatment Center in Nanaimo, BC; Sandstone in Calgary, AB; Bellwood Health Services in Toronto, ON; Gateway Recovery Centre in Peterborough, ON; Clinique Nouveau Depart in Montreal, … Type: Startup Activities: healthtech Technologies: Synthetic Biology | 0 | 0 | 0 | 404 | |
Limbix Digital Therapeutics for Adolescent Mental Health Limbix is passionate about delivering mental health treatment to young people who need it the most, when they need it the most. Our team is uniquely suited to develop prescription digital therapeutics, as we understand the value of pairing clinical expertise with technological innovation. Our diverse team of clinicians, product designers, researchers, and engineers are all focused on one thing: improving the lives of teens through accessible mental health treatment. Cognitive Behavioral Therapy, Mental Health, Digital Therapeutics, and Digital Healthcare Type: Startup Activities: healthtech Technologies: Synthetic Biology | 2 | 0 | 1 | 6 | |
OncoDNA OncoDNA is a genomic and theranostic company specializing in precision medicine for the treatment of cancer and genetic diseases. The company helps clinicians, academic researchers and biopharma companies to outsmart molecular complexity with the mission of delivering the promise of precision medicine. The company not only provides clinical guidance for the treatment and real-time monitoring of late-stage cancer patients but also supports research and drug development in cancer and genetic diseases. Since its early days in 2012, OncoDNA has grown into a corporate group of companies with world-renowned expertise. The Group offers a unique portfolio that combines NGS services, biomarker … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 10 | 3 | 6 | 51 | |
Digital Orthopaedics Clinical decision support systems for musculoskeletal pathologies Digital Orthopaedics is a Digital Health company with the mission to provide a comprehensive Clinical Decision Support System (CDSS) for musculoskeletal pathologies, the foot and ankle in particular. our ambition is to transforms the planning and execution of orthopedic surgeries and treatment with the ultimate goal of Personalizing Orthopedic Treatment through the innovative use of ideation, modeling and 3D simulation. We provide surgeons, patients, and medical devices companies with a state of the art CDSS to identify the optimal treatment and surgical therapeutic plan for each patient and to assist medical device companies … Type: Startup Activities: healthtech deeptech Technologies: A.I. A.I. - Image Processing A.I. - Machine Learning Synthetic Biology | 2 | 2 | 0 | 3 | |
Cellaïon Cell Signaling Technology for Organ Repair and Regeneration Cell Signaling Technology for Organ Repair and Regeneration We care for liver Our advanced therapy aims to restore liver function thanks to immunomodulatory and regenerative properties of Hepastem Cell therapy, Acquired liver diseases, Liver diseases, liver based genetic diseases, NASH, ACLF, Antibodies, Clinical stage, Chronic liver disease, Fatty liver, Acute liver disease, Regenerative medicine, Biotech, and Biotechnology Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 2 | 1 | 1 | 28 | |
Kura Oncology, Inc. Our mission is to realize the promise of precision medicines to help patients with cancer lead better, longer lives. Kura Oncology is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. Our small-molecule drug candidates target signaling pathways and other drivers of cancer where there is a strong scientific and clinical rationale to improve outcomes by identifying those patients most likely to benefit from treatment. Kura’s pipeline consists of three investigational drug candidates: ziftomenib, tipifarnib and KO-2806. Ziftomenib is a once-daily, oral drug candidate targeting the menin-KMT2A protein-protein interaction for the treatment … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 0 | 0 | 0 | 211 | |
Gritstone bio A clinical-stage biotech company that aims to develop the world’s most potent vaccines for cancer and infectious disease Gritstone bio brings together a group of distinguished scientific founders and advisors, a highly experienced and diverse leadership team and a seasoned and successful board of directors to develop the next-generation of vaccines for cancer and infectious disease. With our unique approach to immuno-oncology and infectious diseases, we seek to generate a therapeutic immune response by leveraging insights into the immune system’s ability to recognize and destroy diseased cells by targeting select antigens. We started with a focus on tumor-specific neoantigens and … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 0 | 0 | 0 | 153 | |
Cellarity Rewriting the rules of drug creation Cellarity is fundamentally redesigning the way drugs are created. By shifting the focus from a single target to the underlying cellular dysfunction, the company unravels the complexity of disease biology to create medicines that are out of reach with the target-based drug discovery approach. Founded by Flagship Pioneering in 2017, Cellarity has developed a platform that utilizes proprietary AI models trained on over 30 million single cell transcriptomes to uncover novel actionable biology and create non-intuitive drug candidates in a vast array of diseases. The company currently has programs ongoing in several disease areas … Type: Startup Activities: biotech deeptech Technologies: A.I. Synthetic Biology | 3 | 0 | 3 | 136 | |
Camena Bioscience Unlocking access to genes with unparalleled accuracy Our mission is to enable synthetic biologists, by using our technology to unlock access to genes with unparalleled accuracy. We produce genes for a range of biotechnology customers including those in the pharmaceutical, agriculture and diagnostics sectors. Our technology offers access to long and complex gene sequences, which are normally difficult to produce. We are based in Cambridge UK, but we serve companies across the world. Camena's technology is positioned to enable researchers and the synthetic biology revolution. Twitter: @camenabio DNA synthesis, Complex genes, Synthetic Biology, synbio, and Gene synthesis Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 1 | 0 | 1 | 31 | |
Nuclera Bring rapid protein access to your benchtop with eProtein Discovery At Nuclera, our mission is to better human health by making proteins accessible. We believe that providing rapid access to high-quality, soluble, active proteins at the benchtop will allow researchers to accelerate their protein projects. Fail fast, succeed faster. Our eProtein DiscoveryTM system automates construct screening for the best soluble expression and purification yields of different proteins in under 24 hours. From there, protein scale-up happens the next day (up to the mg scale) right on the benchtop - delivering reliable protein in-hand in less than 48 hours. Nuclera’s technology … Type: Startup Activities: biotech Technologies: Synthetic Biology | 7 | 1 | 4 | 127 | |
Syncath Neuroscience Multimodal diagnostic and therapeutic platform for the Neuro ICU Syncath Neurosience is focused on diagnostics and therapeutics for brain edema and elevated intracranial pressure such as in traumatic brain injuries, subarachnoid hemorrhage and intracranial hemorrhage Type: Startup Activities: deeptech healthtech biotech Technologies: Synthetic Biology SaaS | 0 | 0 | 0 | 2 | |
Cartesian Therapeutics Pioneering RNA cell therapy for autoimmune disease Cartesian Therapeutics is a clinical-stage company pioneering mRNA cell therapies for the treatment of autoimmune diseases. The Company’s lead asset, Descartes-08, is a potential first-in-class mRNA CAR-T in Phase 2b clinical development for patients with generalized myasthenia gravis and Phase 2 development for systematic lupus erythematosus, with a Phase 2 basket trial planned in additional autoimmune indications. The Company’s clinical-stage pipeline also includes Descartes-15, a next-generation, autologous anti-BCMA mRNA CAR-T. For more information, please visit www.cartesiantherapeutics.com Immunotherapy, Oncology, Molecular Biology, Immunology, Autoimmune Diseases, Myasthenia Gravis, ARDS, Cell Therapy, Lung disease, NETs, Cardiovascular Disease, … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 0 | 0 | 0 | 58 | |
SIRNAOMICS Sirnaomics is an RNA therapeutics biopharmaceutical company that focuses on the discovery and development of innovative drugs for indications with unmet medical needs and large market opportunities. Sirnaomics is the first clinical-stage RNA therapeutics company to have a strong presence in both Asia and the United States. Based on its proprietary delivery technologies, a polypeptide nanoparticle RNAi platform and GalNAc RNAi platform, GalAheadTM, Sirnaomics has established an enriched drug candidate pipeline. STP122G, which represents the first drug candidate utilizing the Group's GalAheadTM mxRNA technology, is currently in Phase I development. STP125G is the second siRNA therapeutics based on Sirnaomics proprietary … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 0 | 0 | 0 | 43 | |
Biomica Ltd. Biomica is an emerging biopharmaceutical company developing innovative microbiome-based therapeutics. Biomica is an emerging biopharmaceutical company developing innovative microbiome-based therapeutics utilizing Evogene's Computational Predictive Biology (CPB) platform. Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 0 | 0 | 0 | 22 | |
Oisin Biotechnologies Genetic medicines for age-related diseases Oisin Biotechnologies is a longevity therapeutics platform company focused on creating genetic medicines to combat a variety of age related diseases. When cells detect that they have been irreversibly damaged, they enter a non-dividing condition known as cell-cycle arrest, or senescence. It’s believed this occurs to prevent cells from going rogue and turning cancerous. Ideally, they should die by the process known as apoptosis, but as we age, more and more frequently they don’t. They become zombie cells – unable to kill themselves or resume normal function. Senescent cells secrete molecules that cause inflammation in … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 1 | 0 | 1 | 17 | |
BioAge Labs We are harnessing the biology of human aging to develop novel targets and therapies for metabolic diseases. BioAge is a clinical-stage biotechnology company that is harnessing the biology of human aging to develop novel targets and therapies for metabolic diseases. Our proprietary platform, which encompasses >65M molecular measurements spanning 45+ years of human aging, unlocks a universe of novel biological insights and druggable mechanisms for age-related disease. The company’s lead program, azelaprag, is a potential first-in-class oral APJ agonist entering Phase 2 trials in combination with tirzepatide for the treatment of obesity in older adults. Azelaprag has the potential as … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 6 | 1 | 5 | 90 | |
cellvie Levearging the therapeutic potential of mitochondria cellvie is the leader in Therapeutic Mitochondria Transplantation (TMT). The team is seeking to bring about a novel treatment modality, leveraging the therapeutic potential of mitochondria, the powerhouses of the cell. Therapeutic Mitochondria Transplantation, an approach for mitochondria augmentation and replacement, was developed by Dr. James McCully at Harvard Medical School. cellvie was founded to take this technology from bench to bed, starting in heart attacks and solid organ transplantation. Therapeutic Mitochondria Transfer, Mitochondria, Ischemia-Reperfusion Injury, and Solid Organ Transplantation Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 2 | 0 | 2 | 11 | |
Augustinus Bader Revolutionary Science, Biological Wisdom. For every giant leap in technology, the human body remains our most remarkable machine: this belief has led Professor Augustinus Bader, one of the foremost scientists of his generation, to unlock the body's healing code. His breakthrough medical treatment activates and orchestrates the body's own stem cells to repair and regenerate. From skincare to clinical practice to biotech research, all our advances are grounded in a belief that the body is its own best therapist. Type: Startup Activities: cosmetics Technologies: Synthetic Biology | 1 | 0 | 1 | 190 | |
Confo Therapeutics Exploiting the conformational complexity of GPCRs to innovate drug discovery Confo Therapeutics’ unparalleled technology stabilizes functional conformations of GPCRs (G protein-coupled receptors) to uncover a wide range of previously inaccessible GPCRs as drug targets. This technology platform combined with the pharmacologic and biologic insight it provides, allows Confo to build a multi-indication pipeline of drug candidates with the potential to transform therapeutic outcomes for patients with severe illnesses lacking disease-modifying treatments. Confo Therapeutics was spun out of Vrije Universiteit Brussel (VUB) and VIB in 2015. Supported by international life-science focused investors and led by an experienced team of entrepreneurial professionals … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 0 | 0 | 0 | 68 | |
PAVmed Inc. Nasdaq: PAVM PAVmed (NASDAQ: PAVM) is a highly-differentiated, multi-product medical device company employing a unique and proven business model designed to advance products from concept to commercialization much more rapidly and with significantly less capital than the typical medical device company. This model enables us to pursue an expanding pipeline strategy with a view to enhancing and accelerating value creation. cardiology, orthopedics, gastroenterology, and healthcare economics Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology | 1 | 0 | 1 | 42 | |
MOLECUBES NV Making molecular imaging available to anyone. At MOLECUBES, we believe that molecular imaging should be accessible to every research lab. It is therefore our mission to lower the barrier to preclinical PET, SPECT and CT imaging by providing compact, intuitive, flexible benchtop imaging solutions with the highest performance, supported by fast and simple workflows. With more than 100 CUBES installed worldwide, MOLECUBES is a trusted partner by your side. At MOLECUBES we provide three separate benchtop imagers or “CUBES”: The γ-CUBE is our high-resolution, high-sensitivity micro-SPECT scanner using patented collimator design. The X-CUBE is our high-throughput micro-CT scanner allowing sub-minute … Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 3 | 1 | 1 | 26 | |
Atomo Diagnostics Empowering Healthcare Consumers Atomo Diagnostics is a medical device manufacturer headquartered in Sydney, Australia with offices in South Africa and the United Kingdom. Atomo Diagnostics was established to capitalise on a core belief that healthcare products offering significantly improved levels of convenience, simplicity and user experience are disproportionately disruptive and have the potential to be very successful commercial market entrants. In 2013, Atomo introduced AtomoRapid, a range of safe, simple professional use tests that deliver fast and accurate results in both clinical and community settings. In 2014, AtomoRapid HIV won Best in Show at the Medical Device Excellence Awards (MDEA) … Type: Startup Activities: healthtech deeptech manufacturing Technologies: Synthetic Biology | 0 | 0 | 0 | 28 | |
Helsinn Group Welcome to Helsinn Group's LinkedIn page. This account shall only be used to share news concerning Helsinn. We would like to emphasize that due to the highly regulated nature of the pharma industry, we cannot engage with you online in any discussions concerning our or other companies’ products and/or services, and/or treatment options. It is best to hold such discussions and to seek guidance privately from your healthcare professional. Helsinn is a global pharmaceutical company that builds, manufactures, launches, and commercializes products to improve the quality of life for patients with cancer and chronic disease, with a focus on supportive … Type: SMB Activities: biotech deeptech manufacturing Technologies: Synthetic Biology | 8 | 0 | 2 | 400 | |
CAMBOND LIMITED CAMBOND LIMITED is a medical devices company based out of 1 Mackenzie Rd, Cambridge, CAMBRIDGESHIRE, United Kingdom. Type: SMB Activities: deeptech healthtech Technologies: Synthetic Biology | 2 | 0 | 1 | 3 | |
Santhera Pharmaceuticals We are dedicated to developing medicines to meet the needs of patients living with rare diseases. Santhera Pharmaceuticals (SIX: SANN) is a Swiss specialty pharmaceutical company focused on the development and commercialization of innovative medicines for rare neuromuscular diseases with high unmet medical need. The Company has an exclusive license from ReveraGen for all indications worldwide to AGAMREE® (vamorolone), a dissociative steroid with novel mode of action, which was investigated in a pivotal study in patients with Duchenne muscular dystrophy (DMD) as an alternative to standard corticosteroids. AGAMREE for the treatment of DMD is approved in the U.S. by the … Type: SMB Activities: biotech deeptech manufacturing Technologies: Synthetic Biology | 0 | 0 | 0 | 93 | |
Epithelix Provider of cells, 3D tissues and testing services. Epithelix Sàrl is a Swiss biotech company specialized in human tissue engineering. Epithelix provides innovative R&D solutions for the study of human respiratory diseases (e.g. Asthma, COPD, Cystic Fibrosis, etc.) and for inhalation toxicity testing of chemicals, while reducing the number of animal experiments. Human pulmonary toxicology, Preclinical Drug Development, and Human Tissue Reconstitution Type: SMB Activities: biotech deeptech Technologies: 3D Printing Synthetic Biology | 0 | 0 | 0 | 17 | |
Xeltis Transformative vascular implants. Addressing major life-threatening diseases, backed by Nobel-winning science. Xeltis is developing artificial vessels and valves that are gradually replaced by patients’ own living healthy tissue. www.xeltis.com Type: SMB Activities: healthtech deeptech Technologies: Synthetic Biology | 3 | 2 | 0 | 70 | |
STERIMED Infection Control Healthcare Packaging Materials & Traceability Systems for Medical Device Manufacturers & Patient Care Facilities We are a French group, a leader in the manufacture of sterilization packaging for medical device manufacturers, patient care facilities and the pharmaceutical industry. We are experts in both the manufacture of specialty substrates (paper, polybond®, film, etc.) and the production and supply of ready-to-use sterilization packaging and consumables. As such, we guarantee absolute quality control throughout the supply chain for the utmost safety of patients and caregivers. Concerned with a permanent dynamic of innovation, our R&D teams work on customized developments for our customers and … Type: SMB Activities: deeptech healthtech Technologies: Synthetic Biology | 12 | 1 | 3 | 212 | |
Stem Genomics Next generation quality control for cell therapy Stem Genomics provides dedicated services to assess the genetic integrity of human stem cells. We help research scientists with specific assays and recommended workflows for the cell type they work with. Our flagship testing solution, iCS-digitalTM PSC, has revolutionized in-process genomic stability testing in hPSCs thanks to its high precision, ease and speed. It is particularly interesting for regularly monitoring stem cell lines in culture as well as for screening large numbers of clones, e.g., CRISPR-edited clones or human iPSC clones after reprogramming. We can also perform the following tests for you: G-Banding … Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 2 | 1 | 1 | 12 | |
ExpertsMedTech, Alliance d'experts en santé [Automatic translation follows] The .EMT Alliance supports healthcare professionals from the birth to the success of their projects. The .EMT alliance, a union of recognized players in HealthTech, supports healthcare professionals from the creation of the project to the launch on the market. We intervene at all stages of development and you centralize your actions within the same team of experts in Medtech, Biotech, Pharma, HealthTech. We have created: TALKS! by .emt: 1 annual event dedicated to healthcare professionals with round tables on current topics, keynotes, individual meetings and networking. RISE! with .emt: 2 days of training dedicated to Digital … Type: SMB Activities: deeptech healthtech Technologies: Synthetic Biology | 13 | 2 | 12 | 2 | |
Technoflex The IV drug-delivery expert Technoflex is the independent leader in the design, production and commercialization of I.V. drug delivery bags (standard or customized) and connectors with FDA and EMEA references. With a devoted R&D team, Technoflex offers a specific high value opportunity of taylored products to its partners. Type: SMB Activities: deeptech healthtech manufacturing Technologies: Synthetic Biology | 6 | 2 | 3 | 131 | |
Phost'in Therapeutics Unmask Cancer, Elicit Immune Response Phost’in Therapeutics discovers and develops First-In-Class Glycocalyx Modifiers for selective treatment of cancers and other serious diseases. A new and innovative player in the field of Glyco-Immuno-Oncology, Phost’in Therapeutics develops a class of highly potent anti-cancer NCEs (new chemical entities) targeting a key glycosylation mechanism responsible for suppressing the immune response. Our first generation of Glycosylation inhibitors aims to unblock immune response and down-modulate invasiveness for the treatment of aggressive solid tumors. Glyco Immuno Oncology Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 11 | 6 | 7 | 14 | |
PHARMAOUEST PRÉVENTIX [Automatic translation follows] French manufacturer of medical devices for home care and nursing homes. Pharmaouest Industries, a French manufacturer of medical devices for home care and nursing homes, is today one of the leaders in pressure ulcer prevention aids. After 40 years of existence, owned entirely by family capital, Pharmaouest Industries offers a very wide range for: • home care • the community With a view to constant progress, Pharmaouest Industries has strengthened its technical and commercial skills with the successive acquisitions of the companies MEDIMO in 2004, BARTEX in 2010 and PRÉVENTIX in 2016. Type: SMB Activities: consumer services healthtech manufacturing Technologies: Synthetic Biology | 1 | 1 | 0 | 22 | |
OptimHal-ProtecSom Inspired by your breath® 💡 French designer of medical devices in the fields of asthma and allergy 📍 Normandy, France 🎓 Company certified ISO 13485:2016, medical device standard The Laboratory OptimHal-ProtecSom is a Norman research SME (Small and Medium-sized Businesses) which designs and manufactures in France medical devices for the lung deposition of medicine, asthma and allergy. The company, which dedicates a third of its resources directly to research, expands in part through an assertive politic of partnership: - Partnerships for the distribution of its devices, currently available in 30 countries through a network of 15 exclusive partners. - Partnerships … Type: SMB Activities: deeptech healthtech manufacturing Technologies: Synthetic Biology | 9 | 3 | 3 | 26 | |
VALANX Biotech Superpowering proteins. VALANX Biotech develops a proprietary technology for site-specific protein conjugation for applications in therapeutics, diagnostics and biocatalysis. Bioconjugation, Site-specific conjugation, PEGylation, Biotechnology, and Research and Development Tags: H2020 Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 3 | 1 | 3 | 11 | |
BioNTech R&D (Austria) GmbH Subsidiary of BioNTech SE, now trading as BioNTech R&D (Austria). Developing novel anti-bacterials. BioNTech R&D Austria GmbH (formerly: PhagoMed Biopharma GmbH) is a fully owned subsidiary of BioNTech. The team in Vienna focuses on developing novel anti-bacterial drugs for persistent bacterial infections. Biotech Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology | 2 | 0 | 1 | 7 | |
Virtus Trading LLC (A Virtus Holding Company) Making the difference... VTL has a long proven experience in introducing cutting-edge healthcare equipment and solutions from world-class manufacturers. Their diverse capabilities in Marketing, Sales, Application Support and Service of a wide and comprehensive range of medical equipment and consumables for healthcare facilities, rehabilitation and wellness, makes them a leading solution provider in the region. Established in 2007 with offices in Abu Dhabi, Dubai and Al Ain, Virtus Trading LLC (VTL), from its humble beginnings, today employ more than 30 professionals who have contributed to the 75 Million AED revenue in 2014. VTL offers customers advanced medical management services, medical … Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology | 1 | 0 | 1 | 44 | |
Orio Therapeutics At Orio Therapeutics, our mission is to save lives by making the regenerative medicine dream accessible and a wide-spread reality. We are dedicated to developing novel regenerative drugs with increased efficacy and reduced side-effects, using cutting-edge targeted drug-delivery technologies to create novel therapeutic proteins. Notably, we strive to demonstrate that efficient drug delivery technologies are not confined to the development of complex devices and drug carriers but can be achieved based on clever molecular designs. We aim to initially validate our program pipeline through the development of a therapeutic molecule for myocardial infarction that has the potential to change the … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 1 | 0 | 0 | 1 | |
Pelago Bioscience AB Pelago Bioscience Pelago Bioscience AB is founded to accelerate the use and value of the CETSA® technology in Drug Discovery and diagnostics. We know that the need for Target Engagement studies is large and increasing and there is no single technology with the same opportunities to fill this need as CETSA®. We will: - Make more relevant data available to our customers at an earlier stage of the Drug Discovery process - Enable filtering of compounds based on physiologically relevant data to facilitate better decisions in Drug Discovery programs - Provide our customers with CETSA® based Target Engagement data in … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 1 | 0 | 1 | 60 | |
Intervacc AB A new generation of vaccines based on fusions of recombinant proteins A new generation of vaccines within animal health We develop vaccines based on recombinant proteins to meet the increasing need for effective vaccines in animal health care, with a very good safety profile. Veterinary, Vaccines, Animal Health, Biotech, Recombinant Vaccines, Veterinary Products, Microbiology, Wholesale, and Research and Development Type: Startup Activities: healthtech deeptech manufacturing Technologies: Synthetic Biology | 0 | 0 | 0 | 12 | |
IO Biotech Break Boundaries. Ignite Change. IO Biotech is a clinical-stage biopharmaceutical company pioneering the first-in-class investigational dual-action immune-modulating cancer vaccine with the goal of becoming the backbone of combination therapy for people with cancer. The Company’s T-win® vaccine platform is directed against the tumor microenvironment (TME) and is designed to stimulate T cells against tumor cells and the most important immune-suppressive cells in the TME. IO Biotech’s most advanced program for IO102-IO103 is currently in Phase 3 development. IO Biotech is headquartered in Copenhagen, Denmark. IO Biotech has achieved a proven track record of progressing compounds to the clinic, and has … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 0 | 0 | 0 | 90 | |
Merus N.V. Oncology company developing Biclonics® bispecific antibody therapeutics. See our Community Guidelines: http://bit.ly/36c Merus is developing best-in-class therapeutics to treat and potentially cure cancer patients. Our most advanced development programs use the Biclonics® format. Biclonics® are capable of simultaneously attacking tumors in multiple ways. For example by activating the immune system to kill tumor cells and directly inhibiting tumor cell growth and survival pathways. Working at Merus offers opportunity to grow and develop a career that offers both individual and company success. You have the chance to make an impact within the oncology field by being part of the development of … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 0 | 0 | 0 | 257 | |
Mable Therapy Award-winning Speech Therapy and Counselling service for Schools, Colleges and Local Authorities. Mable has changed the way therapy is delivered in schools; streamlining communication between teacher, therapist and parents and delivering an evidence-based intervention that is not only functional but fun! We create memorable therapeutic experiences for pupils and all teaching staff. Speech and Language Therapy, Digital Health, Telepractice, Edtech, Education, Special Needs, Challenging Behaviour, SEMH, SEND, Speech Pathologist, Online Therapy, Children's Speech Therapy, Counselling, Psychotherapy, Wellbeing, Anxiety, Depression, Autism, Deafness, Developmental Langauge Disorder, Speech delay, and Teaching Type: Startup Activities: edtech kidtech Technologies: Synthetic Biology | 0 | 0 | 0 | 69 | |
Lightcast Profiling function, cell by cell. Lightcast is developing a novel, droplet-based platform that provides a deeper understanding of cellular function. Compared to standard microfluidic methods, the Lightcast platform offers the ability to run a broader range of assays and to precisely control and track the number, occupancy, location, and movement of each droplet. The unprecedented scalability and flexibility of this approach will help advance translational and basic research as well as streamline development workflows for drugs, therapeutics, and applied biologics. Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 0 | 0 | 0 | 111 | |
Bactolife Enhancing global health through scientific food ingredients that fortify the gut microbiome We are on a mission to enhance global gut health and support the fight against antimicrobial resistance. As a Danish biotech firm, we are pioneering the future of gut health with our unique food ingredient, Binding Proteins. Binding Proteins are natural and versatile enough for any food, beverage, or supplement, selectively bind and block harmful microbial activity without disturbing the beneficial microbiome. Our food ingredients are specially formulated for diverse needs, benefiting everyone from mothers and children to the elderly, immune-compromised individuals, travelers, and even animals. Backed by … Type: Startup Activities: healthtech Technologies: Synthetic Biology | 3 | 1 | 2 | 59 | |
Bitome Better tools, faster science Bitome is a Boston-based life sciences tools company that uses metabolomic insights to drive efficient biomanufacturing. Bitome's magnetic-resonance/neural-network-driven platform provides quantified analysis of the cell culture environment -- enabling bio-based products to get to market faster. Our mission at Bitome is to enable the bioeconomy with purpose made tools, so join us as we de-risk industrial biology. Magnetic Resonance, synthetic biology, continuous monitoring, metabolic analysis, lab automation, instrumentation, MEMS, microfluidics, and machine learning Type: Startup Activities: deeptech biotech Technologies: A.I. A.I. - Machine Learning Bio sourced materials Synthetic Biology | 0 | 0 | 0 | 1 | |
ProsFit Our Vision: A world where innovation provides limb wearers a choice of affordable, reliable and desirable prosthetic products and services. Motivation: We aim to play our part in enabling confident mobility, timely rehabilitation, community inclusion, and social integration. Through smart deployment of crucial innovation we want to help build transparent health economics, and attract new talent into the industry. Business model: Supports prosthetic clinic owners to radically improve productivity and user outcomes. Innovation roadmap for transformation of prosthetic service delivery at a global scale. Implementation through scalable business model, sized to fit 20m amputees globally. PandoFit: Proprietary cloud-based cross-platform, modular … Type: Startup Activities: healthtech deeptech Technologies: 3D Printing Synthetic Biology | 1 | 1 | 0 | 8 | |
NanoGenics Nanogenics is an innovative, research-based biotechnology company that specialises in developing bespoke, peptide-based vectors for gene therapy. Nanogenics is proud to introduce LipTideTM; an exciting custom-built delivery vehicle that can be modified to target different cell types and deliver different payloads for all gene therapy. LipTideTM is a peptide nanoparticle that has already shown excellent in vivo efficacy across a range of models and delivery routes, including nebulised and systemic administration. The peptide component performs two functions: it binds the payload to form the core of the nanoparticle and it also triggers receptors on target cells, which cause the cell … Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 0 | 0 | 0 | 1 | |
Fited Omurga Sağlığınız Önceliğimiz. Kişiye Özel Tasarım 3D Korseniz bir haftada hazır. Ücretsiz ön değerlendirme>05426577406 Fited makes patient-specific 3D printed braces. custom-fit, 3d Printed, medical device, medtech, and healthcare Type: Startup Activities: healthtech deeptech Technologies: 3D Printing Synthetic Biology | 3 | 0 | 3 | 8 | |
Biotherm Biotherm is a medical devices company based out of 2163 Glendale Galleria, Glendale, California, United States. Type: SMB Activities: deeptech healthtech Technologies: Synthetic Biology | 5 | 2 | 1 | 65 | |
SEHA Corniche Hospital SEHA Corniche Hospital has a legacy as the most-trusted and leading referral center for Women and Newborn care in Abu Dhabi, with more than 46 years of dedication to motherhood and over 300,000 babies delivered till date. Envisioned by H.H. Sheikha Fatima bint Mubarak, SEHA Corniche Hospital offers a comprehensive range of advanced obstetrics, gynecology, and neonatology services, with subspecialty care services and clinics dealing with fetal medicine, infertility, obstetric medicine, aesthetic gynecology, pain management and allied health disciplines, including lactation and physiotherapy. SEHA Corniche Hospital has a US accreditation as Centre of Excellence for minimally-invasive surgery and endometriosis care, … Type: SMB Activities: healthtech Technologies: Synthetic Biology | 3 | 2 | 0 | 591 | |
Precision BioSciences, Inc. Dedicated to Improving Life. Precision BioSciences, Inc. (Nasdaq: DTIL) is a pre-clinical stage gene editing company developing in vivo gene editing with its highly precise and versatile ARCUS genome editing platform. ARCUS uses sequence-specific DNA-cutting enzymes, or nucleases designed for gene knock out, as well as highly complex edits for gene insertion and/or gene repair. Precision BioSciences is based in Durham, North Carolina. For more information about Precision BioSciences please visit www.precisionbiosciences.com. Gene Editing and Gene Therapy Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 3 | 1 | 1 | 124 | |
Abtech Therapeutics Expertise in protein engineering | in silico & in vitro antibody discovery platform We work in partnership with technology platforms, pharmaceutical companies, and academic research groups to create next generation cell and molecular therapies. We integrate novel technologies into a synthetic antibody platform to provide the most advanced discovery engine possible. Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 2 | 2 | 0 | 2 | |
GROUPE JBT [Automatic translation follows] Let's build tomorrow's medical devices together JBT Group specializes in the design and manufacture of molds and the injection of technical plastic parts for the industrial and medical sectors. A family business with 60 years of experience, a leader in the high-tech tooling and injected products segments for medical and pharmaceutical applications, the Group is constantly developing. Employing 700 employees, the Group achieves a turnover of nearly 90 million euros. Managed from the historic site of Molinges, in the Jura, the strategic and development activities serve all 4 French sites and 3 international sites. Today, the Group … Type: SMB Activities: deeptech healthtech Technologies: Synthetic Biology | 1 | 1 | 0 | 75 | |
EMA Pharmaceuticals Leading sealing solutions for pharma- and diagnostic applications - Made in France. EMA Pharmaceuticals is a global actor in the development, manufacturing and marketing of sealing solutions for pharmaceutical containers. Specifically focused on closures for parenteral drug applications, EMA Pharmaceuticals currently serve more than 170 production sites of injectable medicine across the 5 continents. Our ambition is to enhance patients’ safety by providing Pharmaceutical Industry worldwide with clean-certified closure systems, manufactured according highest industry standards, ensuring optimal product integrity, drug recognition and ease of use by healthcare workers. Closure Systems for Pharmaceutical Containers, Primary Packaging Materials for Parenteral Drugs, and … Type: SMB Activities: deeptech manufacturing biotech Technologies: Synthetic Biology | 0 | 0 | 0 | 38 | |
Nesa Medtech NESA MEDTECH PRIVATE LIMITED is a medical device startup working towards excellence in the Research & Development of Medical devices for emerging countries specifically India, and believes in pursuing business through innovation and technology. This is focused on delivering minimally invasive therapeutic devices innovation to address social and economic burden. NESA MEDTECH is mentored and supported by Department of Biotechnology, Government of India and Karnataka Biotechnology and information technology services. Type: Incubators & VCs Startup Activities: healthtech deeptech Technologies: Synthetic Biology | 2 | 0 | 2 | 18 | |
Solar Foods We are introducing a game-changing natural protein for the global food industry. #NextGenEU #NextGenerationEU Solein is a game-changing protein for the global food industry. Produced from air – CO2, water, nitrogen – and electricity, our unique natural single-cell proteins are not dependent on agriculture, weather or the climate. Creating the future of sustainable food with an unlimited diversity of proteins. #NextGenEU #NextGenerationEU Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 19 | 5 | 12 | 56 | |
Theseus Pharmaceuticals Theseus is developing best-in-class kinase inhibitors to shape the future of targeted oncology. Theseus Pharmaceuticals is passionately committed to outsmarting cancer resistance. Cancer is constantly mutating, allowing it to evade initially effective oncology treatments. Theseus believes we can predict how cancer will change, enabling new therapies to stay ahead of future mutations and overcome the demonstrated burden of treatment resistance. Led by a team of pioneers in the discovery and development of tyrosine kinase inhibitors (TKIs), we are developing best-in-class, pan-variant kinase inhibitors, to shape the future of targeted oncology. PLEASE NOTE: All open positions for Theseus Pharmaceuticals will be … Type: Startup Activities: it services Technologies: A.I. Synthetic Biology | 0 | 0 | 0 | 31 | |
UrSure, Inc. UrSure makes patient-friendly diagnostic tests that measure and improve adherence to medications. UrSure makes urine tests to help doctors and patients improve medication adherence. We are initially focused on drugs to prevent and treat HIV infections. We have received over $2M in funding including winning the Harvard Business School's New Venture Competition and the Harvard President's Innovation Challenge as well as a Phase I and II SBIR from the NIH. We are currently working to scale up our lab based test, which is commercialized and on the market while we complete development of our Point of Care test which will … Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology | 2 | 0 | 1 | 1 | |
LA MER Our journey began when Dr. Max Huber suffered burns in a lab accident and was inspired to create his own destiny. Aerospace Physicist by day, star-gazer and dreamer by night, he hoped to unlock the legendary healing powers of the sea he held so dear. 6,000 experiments and 12 years of searching led to the epiphany of a lifetime – a fermentation process that transformed sea kelp and other pure ingredients into Miracle BrothTM. This cell-renewing elixir at the heart of Crème de la Mer would finally transform the look of his skin. For more LA MER, visit... https://www.cremedelamer.com/ https://www.instagram.com/lamer … Type: Startup Activities: cosmetics deeptech Technologies: Synthetic Biology | 0 | 0 | 0 | 331 | |
Grillido GmbH [Automatic translation follows] Enjoyment with a clear conscience and strong nutritional values. At Grillido, we place particular emphasis on high-quality raw materials and a balanced nutritional profile for our products. We are proud to enable enjoyment without sacrifice, be it through our delicious sausages for meat lovers, protein-rich grilled cheese for cheese fans or a wide range of veggie alternatives. Our goal is to promote a healthier future and to inspire customers with the best taste experiences. We focus on quality and innovation. Type: Startup Activities: foodtech Technologies: Synthetic Biology | 0 | 0 | 0 | 15 | |
LenioBio Rapid eukaryotic, cell-free protein expression that scales for research, development and production. At LenioBio, we develop efficient, robust and sustainable technologies to disrupt the way medicines and food are produced for those in need, wherever they are. Unconstrained by the limitations of cells, we combine our proprietary protein technology with machine learning to significantly accelerate innovation cycles in life science industry. Protein Expression, Protein Production, Synthetic Biology, Biotechnology, Membrane proteins, Antibodies, Functional Proteins, Sustainable Foods, Vaccines, Therapeutic Proteins, Structural Biology, Cell-free protein production, Cell-free protein expression, and Plant-based protein Type: Startup Activities: biotech deeptech manufacturing Technologies: A.I. A.I. - Machine Learning Bio sourced materials Synthetic Biology | 7 | 1 | 6 | 51 | |
64x Bio An evolution in cell line engineering. High throughput engineering of cell lines to enhance the design and manufacture of next-generation therapeutics. Gene therapy, Synthetic Biology, Genome Engineering, and Functional Genomics Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 2 | 1 | 0 | 23 | |
Epiminder Epiminder is a medical device company developing the next generation brain monitoring technology. The company’s first product, the MinderTM system, is an implantable EEG monitoring system designed to detect epileptic seizures. Through long term and continuous EEG measurements, the system will provide unparalleled insights into brain activity, significantly improving the diagnosis and management of epilepsy and helping people with epilepsy take back control of their lives. Epilepsy is complex neurological condition which affects over 80 million people worldwide, 30% of whom don’t respond to medication. The MinderTM system consists of a small implant placed just under the scalp, a multi-channel … Type: Startup Activities: deeptech healthtech Technologies: A.I. Synthetic Biology | 0 | 0 | 0 | 26 | |
Neogene Therapeutics Pushing the frontier by pioneering next-generation engineered T cell receptor therapies for solid cancers Neogene Therapeutics is a global, clinical-stage biotechnology company pioneering the discovery, development, and manufacturing of next-generation engineered T cell receptor (TCR) therapies targeting a broad spectrum of solid cancers. With offices in Santa Monica, CA and Amsterdam, the Netherlands, Neogene is aiming to change the paradigm of treatment for solid cancers. Neogene is a member of the AstraZeneca Group. Type: Startup Activities: biotech deeptech manufacturing Technologies: Synthetic Biology | 1 | 0 | 1 | 188 | |
XING Technologies XING Technologies has a clear vision in applying diagnostic nanotechnologies to globally enhance healthcare systems. We are an Australian-owned and operated cancer pathology lab that uses genetic sequencing to inform doctors and patients about precision cancer treatment options. Precision medicine offers cancer patients therapy options that are targeted specifically to their cancer. XING Genomic Services offers a range of cancer genetic tests for both newly diagnosed cancer patients and patients dealing with a recurrence of their disease. The results analysed in our lab will determine whether the genetic alterations found in your cancer match genetic changes that are associated with … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 0 | 0 | 0 | 3 | |
PrimeCell Advanced Therapy, a.s. [Automatic translation follows] PrimeCell Therapeutics is a Czech biotechnological company focused on the field of regenerative medicine and modern therapy, whose goal is to develop and manufacture Advanced Therapies Medicinal Products that improve people's quality of life. The company PrimeCell Therapeutics was founded in 2007 with the aim of building globally competitive hi-tech centers in the Czech Republic, which will be involved in the global process of development of modern cell therapy. PrimeCell Therapeutics enables doctors and patients with new treatment methods that use human cells and new materials, such as nanomaterials, to treat serious diseases. Thanks to its unique … Type: Startup Activities: deeptech manufacturing Technologies: New Materials Synthetic Biology | 0 | 0 | 0 | 16 | |
Kinoxis Therapeutics Pty Ltd Kinoxis Therapeutics is a private, Australian-based, clinical stage biotechnology company developing first-in-class therapeutics to address the escalating demand for effective treatments for substance use disorders and social dysfunction in neurological and psychiatric disorders. Kinoxis’ development candidates are novel, small molecules that were discovered through a comprehensive medicinal chemistry and screening program at the University of Sydney. Kinoxis is backed by Uniseed, Australia’s longest running venture fund, and a consortium of sophisticated investors, and secured funding from the US National Institutes of Health National Institute on Drug Abuse for the development of its lead compound to mitigate opioid withdrawal symptoms. Kinoxis’ … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 1 | 1 | 1 | 16 | |
Starlab We believe in progress through science. Our solutions enable bright minds to change the world. We believe in progress through science. Our solutions enable bright minds to change the world. We are “Passionate for Science”. Since 1998. Our product portfolio specializes in the field of Liquid Handling Technology and laboratory products. Our product portfolio includes laboratory consumables such as pipette tips, single and multi-channel pipettes, cell culture, tubes, PCR consumables, nitrile and latex gloves, and benchtop equipment for general laboratory use. Our products and services are in daily use at research institutions in biological and medical institutes, universities and hospitals, … Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology | 1 | 1 | 0 | 296 | |
Sopharma We have an active and crucial role in raising standards of everyday life, in making people healthier, happier and safer. Sopharma PLC is one of the leading pharmaceuticals company in Bulgaria popular with manufacturing of high-quality medicines, modern businessethic and social responsibility. The highly technological process for development and production of our products is licensed according to the GPP - Good Production Practices. Type: SMB Activities: deeptech Technologies: Synthetic Biology | 0 | 0 | 0 | 617 | |
ALCIS ALCIS IS YOUR PARTNER, from idea to medical market. You have an idea, a concept, a patent, a prototype... Alcis offers you its expertise and equipment to help you achieve your project and have a certified medical device, ready to be marketed. With more than 20 years-experience in the medical device sector, Alcis can provide you with an EC-marked product, from class I to class III, fostering your activity launch and your product development. We can also set up your quality management system and take the role of legal manufacturer. We can manufacture your medical devices within a controlled atmosphere … Type: SMB Activities: deeptech healthtech manufacturing Technologies: Synthetic Biology | 2 | 1 | 1 | 70 | |
Intégrateurs Industriels du Grand Défi Biomédicaments [Automatic translation follows] support for technological innovation for the production of biomedicines There are 6 of them, the Industrial Integrators of the Grand Défi Biomédicaments have the following missions: - to provide project leaders for the development of technologies for the production of biomedicines (new cellular and a-cellular expression systems, online control, new equipment) with the skills and tools required in the production of antibodies, gene therapy vectors, and cell therapies for the successful completion of their projects, - to provide access to standard bioproduction equipment and an environment conducive to research into the transformation of bioproduction equipment and processes, … Type: Incubators & VCs Activities: deeptech biotech Technologies: Synthetic Biology | 0 | 0 | 0 | N/A | |
ANS Biotech Our Services are as Unique as Your Discoveries ANS Biotech, a preclinical CRO dedicated to pain pharmacology, supports drug discovery and development efforts of companies involved in human and animal health, food and nutrition, by providing them with: • Clinically relevant in vivo models for successful R&D of innovative analgesics, especially in the field of inflammatory pain, neuropathic pain and visceral pain ; • Customized scientific studies meeting drug discovery and development objectives ; • Consulting activities. ANS Biotech also offers ALGOGramTM, a unique in vivo screening tool that provides a rapid and cost-effective means to systematically explore pain indications … Type: SMB Activities: biotech deeptech healthtech Technologies: Synthetic Biology | 3 | 2 | 1 | 23 | |
Abcell-bio Human primary cells to enhance your research Specialized in cell culture, Abcell-bio has a 10-year background and experience in Stem Cell Research and Development. Abcell-bio team is composed of experts that can advise you for your research projects. Our technical team is trained to produce high-quality products in the fields of hematopoiesis and vascular biology. We can process several cell types extracted from: * Cord Blood: CD34+ cells, CD133+ cells, CD34- cells, MonoNuclear Cells (MNCs), Endothelial Progenitor Cells (EPCs) * Umbilical Cord (Human Umbilical Vein/Arterial Endothelial Cells (HUVEC, HUAEC) We also created Cell Culture Media to match your needs for … Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 1 | 1 | 0 | 10 | |
ASKORN MEDICAL Experts in medical devices design & development, quality assurance and regulatory affairs. Design, development and manufacturing of medical devices, from class I to class III. Consulting on Quality Assurance and Regulatory Affairs ISO 13485 : 2016 certified company by French Notified Body GMED. Registered with the FDA. Affaires réglementaires, Conseil en qualité, and Conception de dispositifs médicaux classe I à III Type: SMB Activities: deeptech healthtech manufacturing Technologies: Synthetic Biology | 1 | 0 | 1 | 6 | |
TB TB is an internet company. Type: Startup Activities: healthtech Technologies: Synthetic Biology | 6 | 2 | 1 | 652 | |
Spectroplast AG Breaking boundaries by leading the industrial revolution in unprecedented elastomer solutions Spectroplast is an On-Demand Service Provider for end-use silicone products that are functional and perform. What many industries have tried for years, Spectroplast has achieved with Silicone Additive Manufacturing, making silicones accessible to Industry 4.0. For the first time, end-use silicone products are directly fabricated without the use of molds, saving costs, time while offering an unprecedented freedom of design: - Shore Hardness A20, A35, A50 and A60 - Highest precision 3D Printing, Silicone, Silicone 3D Printing, Soft materials, High precision 3D printing, Additive Manufacturing, Medical, Manufacturing, Technical, Healthcare, … Type: Startup Activities: industry 4.0 manufacturing Technologies: 3D Printing Synthetic Biology | 3 | 0 | 1 | 12 | |
German Bionic We got your back – Smart tools for the future of human physical work. German Bionic is a European robotics firm that develops and manufactures smart power suits and other wearable technologies. It was the world’s first company to deliver connected exoskeletons for the workplace, applying self-learning and artificial intelligence to support lifting movements and prevent poor posture, and thereby becoming an intelligent link between humans and machines. The German Bionic smart power suits and wearables protect the health of workers and markedly reduce the risk of accidents and injury to consequently improve work processes. In recognition of this innovative … Type: Startup Activities: it services manufacturing Technologies: Robotics Synthetic Biology | 12 | 2 | 11 | 77 | |
Enovis We are a medical technology company focused on developing clinically differentiated solutions that generate measurably better patient outcomes and transform workflows. Powered by a culture of continuous improvement, extraordinary talent and innovation, we ‘create better together’ by partnering with healthcare professionals. Our extensive range of products, services and integrated technologies fuel active lifestyles. orthopedics and animal health Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology | 2 | 1 | 1 | 3,045 | |
Comphya Providing a better solution for non-responders to oral drugs. Comphya is a Swiss medical device company, spin-off from the Swiss Federal Institute of Technology (EPFL). Its mission is to overcome the major clinical problems of erectile dysfunction (ED) in spinal cord injury and post-prostatectomy patients (non-responders to oral drugs). Our innovation lies on neuroprosthetics principles and will offer a unique and superior treatment for ED. Our goal is to fulfill patient needs through safe and effective medical devices, offering life quality in large parts of the male population in great need. Urology, Medical Devices, Neuroprosthetics, and Erectile Dysfunction Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology | 1 | 1 | 0 | 9 | |
Aseptuva Aseptuva is a Swiss-UK Medtech startup, with offices in Bern, Zurich & Cambridge, working to prevent hospital infections We are developing a series of medical devices in the Class II (a,b) category, for in-situ disinfection of catheters and tubes inserted into patients inside an ICU environment, as well as on the outside. Our automated and targeted solution strives to prevent secondary infections in hospitals such as VAP, CLABSI etc, thereby reducing the burden on healthcare workers, and improving the overall patient experience by shortening hospital stay and saving additional costs. Type: Startup Activities: healthtech Technologies: Synthetic Biology | 5 | 1 | 4 | 7 | |
INCAPTEK Swiss start-up developing advanced drug delivery systems for biotech/medtech and high-performance materials. INCAPTEK Sàrl is a start-up from Switzerland developing advanced drug delivery systems and technologies to produce high-performance materials. We design smart micro(nano)encapsulation solutions and highly innovative materials for controlled and targeted drug delivery for biotech and medtech industries. We deliver drugs at the right place, in the right dosage, and at the right time, bringing treatment outcomes to the next level. Our technologies can be used as a standalone drug delivery platform for pharmaceuticals and genetic material, as well as for drug-eluting coatings for implantable medical devices and … Type: Startup Activities: deeptech nanotech Technologies: Synthetic Biology New Materials | 0 | 0 | 0 | 2 | |
Medyria Smooth and effective cardiovascular procedures Medyria is a Swiss medtech company that engineers technologies for endovascular catheter navigation and sensing. Medyria objective is to make catheter based procedures faster, safer and more effective. Medyria is based In Technopark, Winterthur., Switzerland Medical Devices, EVAR , Technopark Winterthur, and Swiss Startups Type: Startup Activities: healthtech Technologies: Synthetic Biology | 0 | 0 | 0 | 12 |